ECVUE Advantages

Heart disease is the number one cause of death in the United States. Cardiac arrhythmias—an irregular heartbeat—affects 2.2 million Americans. Congestive heart failure—the inability to pump blood properly—affects nearly 5 million Americans. Conventional treatments such as ablation and cardiac resynchronization therapy (CRT) can improve patients’ lives; but clinical outcomes have not reached the intended levels of success.

Catheter ablation success rates have ranged between 40-85 percent, resulting in need for repeat procedures in 40-50 percent of the cases. For CRT patients, success is highly dependent on selecting the right patient, placing the lead in the best location for that patient, and optimizing the device settings. Currently, 1/3 of all patients with CRT devices do not respond to treatment, leading to continued progression of heart failure, increased patient morbidity, and an increasing financial burden to the healthcare system.

CardioInsight's ECVUE system offers a number of significant clinical benefits…making the diagnosis and treatment guidance of arrhythmias and heart failure simpler, faster, and safer.

• Unique advanced cardiac mapping of complex, intermittent, & unstable arrhythmias, including atrial fibrillation
• Optimize CRT lead placement
• Improve CRT patient selection